DHG Pharmaceutical JSC (DHG) — Cash Flow Reinvestment Rate
DHG Pharmaceutical JSC (DHG) has a Cash Flow Reinvestment Rate of 0.03x as of December 2025, reinvesting ₫14.65 Billion (capex ₫14.65 Billion ) from operating cash flow of ₫447.50 Billion. Check cash flow quality index of DHG Pharmaceutical JSC to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
DHG Pharmaceutical JSC Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for DHG Pharmaceutical JSC across 7 annual periods. Explore DHG operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for DHG Pharmaceutical JSC (2019–2025)
Year-by-year capital reinvestment analysis for DHG Pharmaceutical JSC. For live market cap and broader valuation context, see DHG stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (VND) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | ₫42.21 Billion | ₫1.22 Trillion | ₫42.21 Billion | ▼ -91.5% |
| 2024 | 0.41x | ₫534.66 Billion | ₫1.32 Trillion | ₫88.70 Billion | ▼ -88.1% |
| 2023 | 3.42x | ₫957.17 Billion | ₫279.88 Billion | ₫432.73 Billion | ▲ +1199.5% |
| 2022 | 0.26x | ₫237.20 Billion | ₫901.28 Billion | ₫233.99 Billion | ▲ +383.1% |
| 2021 | 0.05x | ₫24.65 Billion | ₫452.44 Billion | ₫24.56 Billion | ▼ -53.8% |
| 2020 | 0.12x | ₫97.43 Billion | ₫826.17 Billion | ₫88.81 Billion | ▲ +50.4% |
| 2019 | 0.08x | ₫65.73 Billion | ₫838.24 Billion | ₫57.10 Billion | — |